AmyAmundsonSmithMD

Pediatric Hematology & Oncology • Orlando, FL

Pediatric Neuro-Oncology

Division Chief, Pediatric Hematology/Oncology Director, Pediatric Neuro-Oncology Orlando Health-Arnold Palmer Hospital for Children

Join to view full profile

Dr. Smith is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Smith's full profile

Already have an account?

Office
92 W Miller St
Orlando, FL 32806
Phone+1 321-841-8588

Fax+1 321-841-8560

Summary

Dr. Amy Smith is a pediatric hematologist/oncologist in Orlando, FL and is affiliated with Arnold Palmer Hospital for Children-Orlando Health. She received her medical degree from Medical College of Georgia School of Medicine and has been in practice 20 years. She specializes in pediatric neuro-oncology and is experienced in pediatric neuro-oncology.

Education & Training

University of ColoradoFellowship, Pediatric Hematology/Oncology, 2000 - 2003
University of ColoradoResidency, Pediatrics, 1997 - 2000
Medical College of Georgia at Augusta UniversityClass of 1997

Certifications & Licensure

FL State Medical License 2003 - 2025
TX State Medical License 2000 - 2015
CO State Medical License 2000 - 2005
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 14
Active, not recruiting
Phase 3
External Beam Radiation Therapy and Cetuximab Followed by Irinotecan and Cetuximab for Children and Young Adults With Newly Diagnosed Diffuse Pontine Tumors and High-Grade Astrocytomas Start of enrollment: 2009 Oct 30
Completed
Phase 2
Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma Start of enrollment: 2010 May 07
Active, not recruiting
Phase 3
Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma Start of enrollment: 2010 Nov 22
Active, not recruiting
Phase 3
Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors Start of enrollment: 2011 Feb 09
Completed
Phase 1, Phase 2
Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma Start of enrollment: 2019 Jul 08
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

Fibroblast growth factor receptor 1 gene mutation as a potential risk factor for spontaneous intracranial hemorrhage in pediatric low-grade glioma patients.
Maxine Gonzalez-Vega, Brittany M Lebert, Stephani Campion, Aaron Wagner, Ana Aguilar-Bonilla
Neuro-Oncology Advances. 2024-06-04
4 citations
Unraveling the complexity of the senescence-associated secretory phenotype in adamantinomatous craniopharyngioma using multimodal machine learning analysis.
Eric W Prince, John R Apps, John Jeang, Keanu Chee, Stephen Medlin
Neuro-Oncology. 2024-06-03
A multi-institutional pediatric dataset of clinical radiology MRIs by the Children's Brain Tumor Network.
Ariana M Familiar, Anahita Fathi Kazerooni, Hannah Anderson, Aliaksandr Lubneuski, Karthik Viswanathan
Arxiv. 2023-10-02